Scarica l'app Stockscreener
2.26
9.71%
0.20
Pre-mercato:
2.27
0.01
+0.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.06
Aprire:
$2.07
Volume 24 ore:
2.78M
Relative Volume:
2.39
Capitalizzazione di mercato:
$155.27M
Reddito:
$832.00K
Utile/perdita netta:
$-135.12M
Rapporto P/E:
-0.3711
EPS:
-6.09
Flusso di cassa netto:
$-124.69M
1 W Prestazione:
+8.13%
1M Prestazione:
+10.24%
6M Prestazione:
+13.00%
1 anno Prestazione:
-2.59%
Intervallo 1D:
$2.03
$2.3689
Intervallo di 1 settimana:
$2.03
$2.3689
Portata 52W:
$1.30
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Nome
Inovio Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 410-3134
Indirizzo
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Confronta INO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.26 | 141.53M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2024-01-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Downgrade | Maxim Group | Buy → Hold |
| 2022-11-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Ripresa | Jefferies | Hold |
| 2021-09-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Iniziato | Jefferies | Hold |
| 2021-03-23 | Iniziato | BofA Securities | Neutral |
| 2021-02-12 | Iniziato | Oppenheimer | Outperform |
| 2020-11-17 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Aggiornamento | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-07-01 | Downgrade | Maxim Group | Buy → Hold |
| 2020-07-01 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Downgrade | Stifel | Buy → Hold |
| 2020-05-21 | Iniziato | The Benchmark Company | Buy |
| 2020-04-30 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Iniziato | ROTH Capital | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
| 2017-10-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-09-06 | Iniziato | Citigroup | Buy |
| 2017-06-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Reiterato | Maxim Group | Buy |
| 2017-03-16 | Aggiornamento | Maxim Group | Hold → Buy |
| 2017-03-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
Mostra tutto
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
JANUS HENDERSON GROUP PLC Expands Stake in Inovio Pharmaceuticals Inc - GuruFocus
Inovio Pharmaceuticals Inc Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in
Inovio Pharmaceuticals (NASDAQ:INO) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Will Inovio Pharmaceuticals Inc. stock see insider buying2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
How Inovio Pharmaceuticals Inc. stock performs in weak economyWeekly Trade Analysis & Fast Gaining Stock Reports - Newser
Inovio Pharmaceuticals drops 6%, proposes equity offering - MSN
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsJuly 2025 Rallies & Stock Timing and Entry Methods - Newser
Inovio Pharmaceuticals Inc. Stock Advances 5.2%, Outperforms Market - 富途牛牛
Will Inovio Pharmaceuticals Inc. (GBM) stock beat value stocksEarnings Performance Report & Weekly Stock Performance Updates - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock good for wealth creationTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthMarket Movement Recap & Stepwise Trade Signal Implementation - Newser
Is Inovio Pharmaceuticals Inc. (GBM) stock expanding market penetrationDollar Strength & High Conviction Investment Ideas - Newser
INO: INO-3107 shows strong efficacy and safety in RRP, with launch preparations underway for 2025 - TradingView — Track All Markets
Trend Recap: Will Inovio Pharmaceuticals Inc stock see insider buying2025 Volatility Report & Low Risk High Win Rate Picks - BỘ NỘI VỤ
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosJuly 2025 Trends & AI Based Buy/Sell Signal Reports - Newser
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Is Inovio Pharmaceuticals Inc. (GBM) stock a top dividend aristocrat candidateJuly 2025 Movers & Weekly Momentum Stock Picks - moha.gov.vn
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults (PR Newswire) - Aktiellt
INOVIO Maps Out High-Stakes December as Investors Eye Rare Disease Catalysts - MyChesCo
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
What analysts say about Inovio Pharmaceuticals Inc GBM stockStock Buyback Updates & High Return Portfolio Growth - earlytimes.in
How strong is Inovio Pharmaceuticals Inc. (GBM) stock earnings growth2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
What sentiment indicators say about Inovio Pharmaceuticals Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock gain from lower interest ratesWeekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MyChesCo
Why Inovio Pharmaceuticals Inc. stock is favored by top institutions2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is Inovio Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Inovio Pharmaceuticals Inc. (GBM) stockMarket Growth Review & Weekly Return Optimization Alerts - newser.com
HC Wainwright Issues Optimistic Forecast for INO Earnings - MarketBeat
Published on: 2025-11-20 00:40:52 - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock survive global slowdownTrend Reversal & Low Volatility Stock Recommendations - newser.com
Will Inovio Pharmaceuticals Inc. (GBM) stock attract long term capital inflows2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock inflation resilientEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsDollar Strength & AI Enhanced Execution Alerts - newser.com
What is the fair value estimate for Inovio Pharmaceuticals Inc. (GBM) stock in 2025 - newser.com
Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):